We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,549 results
  1. Non-calcified active atherosclerosis plaque detection with 18F-NaF and 18F-FDG PET/CT dynamic imaging

    Arterial inflammation is an indicator of atheromatous plaque vulnerability to detach and to obstruct blood vessels in the heart or in the brain thus...

    Abdelillah Douhi, Mamdouh S. Al‑enezi, ... M’hamed Bentourkia in Physical and Engineering Sciences in Medicine
    Article 30 January 2023
  2. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis

    Background

    As a first-line imaging modality, whole-body fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed...

    Cici Zhang, Zhishan Liang, ... Yuzhen Mo in BMC Cancer
    Article Open access 10 January 2023
  3. [18F]FDG PET/CT Imaging in Cancer Treatment with Checkpoint Inhibitors

    In the last decade, the development of new therapeutic agents modulating the activity of the immune system and boosting its response against cancer...
    Barbara Catalfamo, Egesta Lopci in Handbook of Cancer and Immunology
    Living reference work entry 2023
  4. Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS study

    Metabolic elevation in soft-tissue sarcomas (STS), as documented with 18 F-Fluorodeoxyglucose positron emission tomography ( 18 F-FDG-PET/CT) has been...

    Amandine Crombé, Frédéric Bertolo, ... Antoine Italiano in Biomarker Research
    Article Open access 07 January 2024
  5. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation

    Purpose

    Our study was to investigate the correlation correlation between FDG uptake and PD-L1 expression of liver metastasis in patients with colon...

    Yan Qiao, **aomeng Li, ... Hong Sun in BMC Cancer
    Article Open access 12 June 2023
  6. Prognostic value of maximum standard uptake value, metabolic tumour volume, and total lesion glycolysis of 18F-FDG PET/CT in patients with malignant pleural mesothelioma: a systematic review and meta-analysis

    Purpose

    Present work systematically reviewed relevant literature based on 18F-FDG PET parameters and conducted a meta-analysis to examine the...

    Weibo Wen, Dongyuan Xu, ... **angdan Li in Cancer Cell International
    Article Open access 03 February 2022
  7. Cancer Staging with 18F-FDG PET/CT in Hyperglycemic Patients

    In oncology positron emission tomography/computed tomography (PET/CT) is a standard imaging procedure for cancer staging, restaging, treatment...
    Monica Finessi, Virginia Liberini, Désirée Deandreis in Obesity and Diabetes
    Chapter 2020
  8. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial

    Background

    The outcome of patients with muscle-invasive bladder cancer (MIBC) remains poor, despite aggressive treatments. Inadequate primary staging,...

    Flor Verghote, Lindsay Poppe, ... Valérie Fonteyne in BMC Cancer
    Article Open access 18 October 2021
  9. Multi-stage classification of Alzheimer’s disease from 18F-FDG-PET images using deep learning techniques

    The study aims to implement a convolutional neural network framework that uses the 18F-FDG PET modality of brain imaging to detect multiple stages of...

    Mahima Thakur, U. Snekhalatha in Physical and Engineering Sciences in Medicine
    Article 10 November 2022
  10. Gene’s expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study

    Background

    Positron Emission Tomography (PET) imaging with Prostate-Specific Membrane Antigen (PSMA) and Fluorodeoxyglucose (FDG) represent promising...

    Matteo Bauckneht, Cecilia Marini, ... Gianmario Sambuceti in Journal of Translational Medicine
    Article Open access 04 January 2023
  11. The prognostic power of 18F-FDG PET/CT extends to estimating systemic treatment response duration in metastatic castration-resistant prostate cancer (mCRPC) patients

    Background

    We aimed to test whether the prognostic value of 18 F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) in...

    Matteo Bauckneht, Francesco Bertagna, ... Domenico Albano in Prostate Cancer and Prostatic Diseases
    Article Open access 19 May 2021
  12. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach

    The recent progress in the development of in vivo biomarkers is rapidly changing how neurodegenerative diseases are conceptualized and diagnosed and...
    Elena Rodriguez-Vieitez, Amit Kumar, ... Konstantinos Chiotis in Biomarkers for Alzheimer’s Disease Drug Development
    Protocol 2024
  13. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer’s disease and amnestic mild cognitive impairment

    Background

    The aim of this study was to compare Dynamic Susceptibility Contrast Enhanced MRI (DSC-MRI) and PET with [18F]flurodeoxyglucose (FDG-PET)...

    Aleksandra Wabik, Elżbieta Trypka, ... Anna Zimny in Journal of Translational Medicine
    Article Open access 07 June 2022
  14. Feature-based Quality Assessment of Middle Cerebral Artery Occlusion Using 18F-Fluorodeoxyglucose Positron Emission Tomography

    In animal experiments, ischemic stroke is usually induced through middle cerebral artery occlusion (MCAO), and quality assessment of this procedure...

    Wuxian He, Hongtu Tang, ... Weichuan Yu in Neuroscience Bulletin
    Article 31 May 2022
  15. Expanding the Spectrum of Stress-Induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures (CONDSIAS)

    Stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (CONDSIAS) is an extremely rare, autosomal recessive...

    Filippa Orlien Lindskov, William Kristian Karlsson, ... Jørgen Erik Nielsen in The Cerebellum
    Article 01 July 2023
  16. Longitudinal trimodal imaging of midbrain-associated network degeneration in Parkinson’s disease

    The prevailing network perspective of Parkinson’s disease (PD) emerges not least from the ascending neuropathology traceable in histological studies....

    Kenan Steidel, Marina C. Ruppert, ... Carsten Eggers in npj Parkinson's Disease
    Article Open access 22 June 2022
  17. Radiogenomic analysis of primary breast cancer reveals [18F]-fluorodeoxglucose dynamic flux-constants are positively associated with immune pathways and outperform static uptake measures in associating with glucose metabolism

    Background

    PET imaging of 18F-fluorodeoxygucose (FDG) is used widely for tumour staging and assessment of treatment response, but the biology...

    G. P. Ralli, R. D. Carter, ... J. D. Fenwick in Breast Cancer Research
    Article Open access 17 May 2022
  18. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer

    Background

    The lack of distinct biomarkers for pancreatic cancer is a major cause of early-stage detection difficulty. The pancreatic cancer patient...

    Baek Gil Kim, Sung Hwan Lee, ... Nam Hoon Cho in Journal of Translational Medicine
    Article Open access 13 May 2024
  19. Indirect comparison of the diagnostic performance of 18F-FDG PET/CT and MRI in differentiating benign and malignant ovarian or adnexal tumors: a systematic review and meta-analysis

    Objective

    To compare the value of fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) and magnetic resonance imaging...

    **anwen Hu, Dandan Li, ... Jiong Cai in BMC Cancer
    Article Open access 06 October 2021
Did you find what you were looking for? Share feedback.